Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
1 Nov 2022, 07:15
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis $KPTI
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis $KPTI
1 Nov 2022, 07:09
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis $KPTI
Karyopharm and Menarini Group Announce Orphan Medicinal Product Designation from the European Commission for Selinexor for the Treatment of Myelofibrosis $KPTI
21 Jul 2022, 09:15
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy $KPTI
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy $KPTI
21 Jul 2022, 09:13
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy $KPTI
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy $KPTI
show more ▾
featured articles
April 25, 2024
MINESPIDER AND STAR DIAMOND CORPORATION TO LAUNCH G7 COMPLIANT DIAMOND PASSPORT $DIAM
MINESPIDER AND STAR DIAMOND CORPORATION TO LAUNCH G7 COMPLIANT DIAMOND PASSPORT $DIAM
April 25, 2024
Newcore Gold Announces Positive Updated Preliminary Economic Assessment for the Enchi Gold Project, Ghana $NCAU $NCAUF.US
Newcore Gold Announces Positive Updated Preliminary Economic Assessment for the Enchi Gold Project, Ghana $NCAU $NCAUF.US
April 24, 2024
Silver X Delivers Solid Production Growth During the First Quarter of 2024 $AGX $AGXPF.US
Silver X Delivers Solid Production Growth During the First Quarter of 2024 $AGX $AGXPF.US
April 24, 2024
Bitcoin Well Reports 2023 Q4 and Year End Financial Results $BTCW $BCNWF.US
Bitcoin Well Reports 2023 Q4 and Year End Financial Results $BTCW $BCNWF.US
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
Karyopharm Therapeutics Inc.
KPTI
$KPTI ↻
0 online
Today
This week
Search
Subscribe
Sign up to become a contributing member of the community.
Trending
Personal channels
